The EMEA/CPMP initiative on genotoxic impurities in pharmaceuticals

被引：0
|
作者：
Mueller, L [1 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
来源：
MUTAGENESIS | 2004年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
27
引用
收藏
页码：508 / 508
页数：1
相关论文
共 50 条
  • [1] Genotoxic impurities: the EMEA guideline
    Van Aerts, L.
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A77 - A78
  • [2] Determination of Genotoxic Impurities in Pharmaceuticals
    David, Frank
    Alegre, Maria Rambla
    Vanhoenacker, Gerd
    Sandra, Pat
    [J]. LC GC EUROPE, 2013, : 31 - 34
  • [3] Risk assessment of genotoxic impurities in pharmaceuticals
    Humfrey, Charles
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S39 - S39
  • [4] Advances on genotoxic impurities of sulfonate esters in pharmaceuticals
    Liu Xuewei
    Li Cheng
    Han Haiyun
    Zhang Wenpeng
    Chen Dongying
    [J]. CHINESE JOURNAL OF CHROMATOGRAPHY, 2018, 36 (10) : 952 - 961
  • [5] Risk assessment and management of genotoxic impurities in pharmaceuticals
    Masamitsu Honma
    [J]. 中国药理学与毒理学杂志, 2013, (03) : 575 - 575
  • [6] Management of Genotoxic Impurities in Pharmaceuticals With the Threshold of Toxicological Concern
    McGovern, Timothy J.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 (01) : 131 - 131
  • [7] Method Selection for Trace Analysis of Genotoxic Impurities in Pharmaceuticals
    David, Frank
    Jacq, Karine
    Vanhoenacker, Gerd
    Sandra, Pat
    Baker, Andrew
    [J]. LC GC EUROPE, 2009, 22 (11) : 552 - +
  • [8] Genotoxic and non-genotoxic impurities in pharmaceuticals Current regulations, status and trend
    Roy, Arindam
    Nyarady, Stefan
    Matchett, Michael
    [J]. CHIMICA OGGI-CHEMISTRY TODAY, 2009, 27 (02) : xix - xxiii
  • [9] Evolution of regulatory aspects of genotoxic impurities in pharmaceuticals: Survival of the fittest
    Maithani, Mukesh
    Raturi, Richa
    Gupta, Vikas
    Bansal, Parveen
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (15) : 759 - 769
  • [10] Controlling of genotoxic impurities in pharmaceuticals: International harmonisation of regulatory requirements
    Kasper, P.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S7 - S7
12345